Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

September 28, 2018

Securities and Exchange Commission v. Salix Pharmaceuticals, Ltd.

Track this case

Case Number:

1:18-cv-08886

Court:

New York Southern

Nature of Suit:

Securities/Commodities

Judge:

Andrew L. Carter, Jr

Firms

Companies

Government Agencies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 28, 2018

    Ex-Salix CFO Pays $1M To End Claims He Misled Investors

    The U.S. Securities and Exchange Commission on Friday charged Salix Pharmaceuticals Ltd. and its former chief financial officer with repeatedly misleading investors about the amount of Salix drugs that wholesale customers were holding in inventory, with the executive agreeing to pay $1 million to settle the charges.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login